dpp-4 inhibitors and glp-1 agonists Receptor Have better Outcomes Than DPP4 in T2D patients & CKD Lesson: A Clinical Overview of

[DOI] [PubMed] [Google Scholar] 14.Roth J.D., Roland B.L., Cole R.L., Trevaskis J.L., Weyer C., Koda J.E

SGLT-2 inhibitors, GLP-1 receptor agonists, and DPP-4 inhibitors and risk of hyperkalemia among people with type 2 diabetes in clinical practice: population based cohort study

For those with multiple chronic conditions, complex medication regimens, or clinical situations that warrant a more comprehensive workup before initiating GLP-1 therapy, a traditional relationship with an obesity medicine specialist or endocrinologist may provide a better level of oversight

Yin W, Xu S, Wang Z, Liu H, Peng L, Fang Q, et al

Working with Schwartz, they discovered a hormone called pancreatic polypeptide that has a specific breakdown pattern